5.0
11 Mar 2021
Recommend
CEO approval
Business outlook
Pros
Strong leadership with a supportive culture, promising scientific programs, well-funded and well-differentiated versus other GI and immune companies. I think the company is on a great trajectory.
Cons
Company is growing quickly and still firming up some processes and procedures. Normal growing pains.